$ENTA
ENANTA PHARMACEUTICALS INC

2024 Q3 Form 10-Q Financial Statement

#000095017024092714 Filed on August 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $14.61M $17.97M
YoY Change -22.84% -4.88%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $13.68M $13.41M
YoY Change -0.85% 6.31%
% of Gross Profit
Research & Development $30.78M $28.74M
YoY Change -14.91% -33.14%
% of Gross Profit
Depreciation & Amortization $594.0K
YoY Change -8.76%
% of Gross Profit
Operating Expenses $44.46M $28.74M
YoY Change -11.01% -48.31%
Operating Profit -$24.19M
YoY Change -34.12%
Interest Expense $668.0K $2.355M
YoY Change -55.76% 26.0%
% of Operating Profit
Other Income/Expense, Net $1.132M
YoY Change -39.43%
Pretax Income -$29.19M -$23.05M
YoY Change -1.13% -33.84%
Income Tax -$363.0K -$395.0K
% Of Pretax Income
Net Earnings -$28.82M -$22.66M
YoY Change 2.54% -42.0%
Net Earnings / Revenue -197.32% -126.08%
Basic Earnings Per Share -$1.07
Diluted Earnings Per Share -$1.36 -$1.07
COMMON SHARES
Basic Shares Outstanding 21.19M 21.18M
Diluted Shares Outstanding 21.18M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $248.2M $230.1M
YoY Change -32.91% -40.48%
Cash & Equivalents $37.23M $35.78M
Short-Term Investments $211.0M $194.3M
Other Short-Term Assets $13.02M $15.87M
YoY Change -2.1% -7.05%
Inventory
Prepaid Expenses
Receivables $6.646M $8.176M
Other Receivables $32.00M $32.46M
Total Short-Term Assets $299.9M $286.6M
YoY Change -29.08% -36.1%
LONG-TERM ASSETS
Property, Plant & Equipment $32.69M $25.05M
YoY Change 174.25% -30.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $42.51M
YoY Change 617.59%
Other Assets $94.00K $105.0K
YoY Change -88.29% -97.81%
Total Long-Term Assets $76.80M $112.2M
YoY Change 94.51% 140.32%
TOTAL ASSETS
Total Short-Term Assets $299.9M $286.6M
Total Long-Term Assets $76.80M $112.2M
Total Assets $376.7M $398.8M
YoY Change -18.52% -19.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.002M $10.68M
YoY Change 95.31% 34.58%
Accrued Expenses $13.55M $12.83M
YoY Change -26.13% -45.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $57.54M $58.23M
YoY Change -8.36% -14.6%
LONG-TERM LIABILITIES
Long-Term Debt $1.350M $1.423M
YoY Change -3.57% 0.0%
Other Long-Term Liabilities $231.0K $227.0K
YoY Change -65.16% -99.88%
Total Long-Term Liabilities $231.0K $227.0K
YoY Change -65.16% -99.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $57.54M $58.23M
Total Long-Term Liabilities $231.0K $227.0K
Total Liabilities $247.8M $249.9M
YoY Change 0.94% -2.89%
SHAREHOLDERS EQUITY
Retained Earnings -$323.0M -$294.2M
YoY Change 56.06% 64.47%
Common Stock $451.6M $443.8M
YoY Change 6.27% 6.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $128.8M $148.9M
YoY Change
Total Liabilities & Shareholders Equity $376.7M $398.8M
YoY Change -18.52% -19.46%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$28.82M -$22.66M
YoY Change 2.54% -42.0%
Depreciation, Depletion And Amortization $594.0K
YoY Change -8.76%
Cash From Operating Activities -$14.78M
YoY Change -54.01%
INVESTING ACTIVITIES
Capital Expenditures $6.542M
YoY Change 204.14%
Acquisitions
YoY Change
Other Investing Activities $197.0K
YoY Change -100.14%
Cash From Investing Activities -$6.345M
YoY Change -95.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.647M
YoY Change -103.33%
NET CHANGE
Cash From Operating Activities -14.78M
Cash From Investing Activities -6.345M
Cash From Financing Activities -6.647M
Net Change In Cash -27.77M
YoY Change -226.22%
FREE CASH FLOW
Cash From Operating Activities -$14.78M
Capital Expenditures $6.542M
Free Cash Flow -$21.32M
YoY Change -37.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
50263000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35664000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25212000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23745000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25051000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11919000
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2006000
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1632000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4793000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7037000
CY2024Q2 enta Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
2711000
CY2023Q3 enta Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
6120000
CY2024Q2 enta Accrued Liabilities Manufacturing
AccruedLiabilitiesManufacturing
1581000
CY2023Q3 enta Accrued Liabilities Manufacturing
AccruedLiabilitiesManufacturing
3083000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1739000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
467000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12830000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18339000
dei Entity Central Index Key
EntityCentralIndexKey
0001177648
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35839
dei Entity Registrant Name
EntityRegistrantName
ENANTA PHARMACEUTICALS, INC
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3205099
dei Entity Address Address Line1
EntityAddressAddressLine1
500 Arsenal Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
607-0800
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
ENTA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4365000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
52.68
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M24D
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21188571
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35775000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85388000
CY2024Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
194310000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
284522000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8176000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8614000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15260000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13263000
CY2024Q2 us-gaap Income Tax Receivable
IncomeTaxReceivable
32455000
CY2023Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
31004000
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
608000
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2024Q2 us-gaap Assets Current
AssetsCurrent
286584000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
422791000
CY2024Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
42510000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25051000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11919000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
41211000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22794000
CY2024Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3360000
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3968000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
105000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
803000
CY2024Q2 us-gaap Assets
Assets
398821000
CY2023Q3 us-gaap Assets
Assets
462275000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10675000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4097000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12830000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18339000
CY2024Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
32295000
CY2023Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
35076000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2431000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5275000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
58231000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
62787000
CY2024Q2 enta Accrued Royalties Noncurrent
AccruedRoyaltiesNoncurrent
141889000
CY2023Q3 enta Accrued Royalties Noncurrent
AccruedRoyaltiesNoncurrent
159429000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48136000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21238000
CY2024Q2 enta Non Convertible Preferred Stock Liabilities
NonConvertiblePreferredStockLiabilities
1423000
CY2023Q3 enta Non Convertible Preferred Stock Liabilities
NonConvertiblePreferredStockLiabilities
1423000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
227000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
663000
CY2024Q2 us-gaap Liabilities
Liabilities
249906000
CY2023Q3 us-gaap Liabilities
Liabilities
245540000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21182000
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21182000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21059000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21059000
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
212000
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
211000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
443573000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
424693000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-653000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1174000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-294217000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-206995000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
148915000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
216735000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
398821000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
462275000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17971000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18892000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53028000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60272000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28742000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42987000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
100698000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
127357000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13414000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12618000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44167000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39092000
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
42156000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
55605000
us-gaap Costs And Expenses
CostsAndExpenses
144865000
us-gaap Costs And Expenses
CostsAndExpenses
166449000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-24185000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-36713000
us-gaap Operating Income Loss
OperatingIncomeLoss
-91837000
us-gaap Operating Income Loss
OperatingIncomeLoss
-106177000
CY2024Q2 us-gaap Interest Expense
InterestExpense
2355000
CY2023Q2 us-gaap Interest Expense
InterestExpense
1997000
us-gaap Interest Expense
InterestExpense
8359000
us-gaap Interest Expense
InterestExpense
1997000
CY2024Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3487000
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3866000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
11594000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
6696000
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1132000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1869000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3235000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4699000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23053000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34844000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-88602000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-101478000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-395000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4221000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1380000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4231000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-22658000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-39065000
us-gaap Net Income Loss
NetIncomeLoss
-87222000
us-gaap Net Income Loss
NetIncomeLoss
-105709000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.86
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.05
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21180000
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21180000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21054000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21054000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21145000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21145000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20939000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20939000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-22658000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-39065000
us-gaap Net Income Loss
NetIncomeLoss
-87222000
us-gaap Net Income Loss
NetIncomeLoss
-105709000
CY2024Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
14000
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
311000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
521000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2220000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
14000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
311000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
521000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2220000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22644000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38754000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-86701000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-103489000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
216735000
CY2023Q4 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-183000
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8099000
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
640000
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-33407000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
191884000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
51000
CY2024Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-92000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5561000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-133000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-31157000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
166114000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
28000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5417000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
14000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-22658000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
148915000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
321334000
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1126000
CY2022Q4 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-825000
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7139000
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1049000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-28986000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
300837000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
882000
CY2023Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-2909000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7363000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
860000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-37658000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
269375000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
200000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6998000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
311000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-39065000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
237819000
us-gaap Profit Loss
ProfitLoss
-87222000
us-gaap Profit Loss
ProfitLoss
-105709000
us-gaap Share Based Compensation
ShareBasedCompensation
19077000
us-gaap Share Based Compensation
ShareBasedCompensation
21500000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1857000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1702000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1357000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.98
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.99
enta Non Cash Interest Expense Associated With The Sale Of Future Royalties
NonCashInterestExpenseAssociatedWithTheSaleOfFutureRoyalties
-620000
enta Non Cash Interest Expense Associated With The Sale Of Future Royalties
NonCashInterestExpenseAssociatedWithTheSaleOfFutureRoyalties
1997000
enta Payments For Royalty Liabilities
PaymentsForRoyaltyLiabilities
-514000
enta Payments For Royalty Liabilities
PaymentsForRoyaltyLiabilities
0
enta Premium On Marketable Securities
PremiumOnMarketableSecurities
0
enta Premium On Marketable Securities
PremiumOnMarketableSecurities
73000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-64000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2792000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-7000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-438000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1426000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1997000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3626000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1451000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-2801000
enta Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-4558000
enta Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-3187000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-698000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
134000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1124000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2682000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6047000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3350000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
1079000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1142000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-436000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-28000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-68364000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-81552000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
307283000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
267274000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
355442000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
209550000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8997000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7690000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
39162000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-65414000
enta Payments On Royalty Sale Liability Net Of Imputed Interest
PaymentsOnRoyaltySaleLiabilityNetOfImputedInterest
20215000
enta Payments On Royalty Sale Liability Net Of Imputed Interest
PaymentsOnRoyaltySaleLiabilityNetOfImputedInterest
0
enta Proceeds From Sale Of Future Royalties
ProceedsFromSaleOfFutureRoyalties
0
enta Proceeds From Sale Of Future Royalties
ProceedsFromSaleOfFutureRoyalties
200000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
325000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
275000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3734000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
79000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2208000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20411000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
198149000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-49613000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
51183000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
89356000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
47962000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
39743000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
99145000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6416000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1075000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
22975000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3580000
us-gaap Interest Paid Net
InterestPaidNet
9187000
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-4622000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-1994000
us-gaap Year Founded
YearFounded
1995
us-gaap Net Income Loss
NetIncomeLoss
-87222000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-133816000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-294217000
CY2024Q2 enta Cash Cash Equivalents Short Term And Long Term Marketable Securities
CashCashEquivalentsShortTermAndLongTermMarketableSecurities
272595000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these condensed consolidated financial statements include, but are not limited to, management’s judgments with respect to its revenue arrangements; liability related to the sale of future royalties; valuation of stock-based awards and the accrual of research and development expenses. Estimates are periodically reviewed in light of changes in circumstances, facts and experience.</span></p>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
477000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
40.3
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5236000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
42.82
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4189000
CY2024Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
272339000
CY2024Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1423000
CY2023Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
369634000
CY2023Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1423000
CY2024Q2 enta Fair Value Measurements Inter Transfers Between Levels
FairValueMeasurementsInterTransfersBetweenLevels
0
CY2023Q2 enta Fair Value Measurements Inter Transfers Between Levels
FairValueMeasurementsInterTransfersBetweenLevels
0
enta Fair Value Measurements Inter Transfers Between Levels
FairValueMeasurementsInterTransfersBetweenLevels
0
enta Fair Value Measurements Inter Transfers Between Levels
FairValueMeasurementsInterTransfersBetweenLevels
0
CY2024Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
237089000
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
11000
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
280000
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
236820000
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
285312000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
12000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
802000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
284522000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5236000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
42.82
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y6M
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
4189000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3229000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
51.79
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y1M6D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
498000
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5417000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6998000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19077000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21500000
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5417000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6998000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19077000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21500000
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
40045
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-395000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1380000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4221000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4231000
CY2023Q2 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
200000000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1753000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8223000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8467000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
8721000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
8983000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
59191000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
95338000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
33786000
CY2024Q2 enta Tenant Improvement Allowance
TenantImprovementAllowance
-10985000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
50567000
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-24-092714-index-headers.html Edgar Link pending
0000950170-24-092714-index.html Edgar Link pending
0000950170-24-092714.txt Edgar Link pending
0000950170-24-092714-xbrl.zip Edgar Link pending
enta-20240630.htm Edgar Link pending
enta-20240630.xsd Edgar Link pending
enta-ex31_1.htm Edgar Link pending
enta-ex31_2.htm Edgar Link pending
enta-ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img216962810_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
enta-20240630_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending